Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam adjunctive safety study in children with partial onset seizures
2014-004396-23Phase 2
- Sponsor
- UCB
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in epilepsy comparing Keppra adjunctive treatment with Placebo adjunctive treatment (2 arms). Primary endpoint: Change from baseline in Leiter International Performance Scale-Revised Attention and Memory Battery Memory Screen Composite Score.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2014-004396-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004396-23.